Qube Research & Technologies (QRT)’s TELA Bio TELA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,113
Closed -$25.6K 3812
2024
Q3
$25.6K Sell
10,113
-24,079
-70% -$85.6K ﹤0.01% 2949
2024
Q2
$161K Buy
+34,192
New +$180K ﹤0.01% 2490
2023
Q2
Sell
-19,736
Closed -$210K 3002
2023
Q1
$210K Buy
+19,736
New +$218K ﹤0.01% 1915
2020
Q2
Sell
-20,600
Closed -$161K 1985
2020
Q1
$161K Buy
20,600
+9,700
+89% +$131K 0.01% 909
2019
Q4
$141K Buy
+10,900
New +$133K ﹤0.01% 1435

Other funds holding TELA

Qube Research & Technologies (QRT)'s TELA Position: Q4 2024 in Review

Qube Research & Technologies (QRT) sold out of TELA Bio (TELA) in Q4 2024, closing a stake of 10,113 shares — an estimated $25.6K sold.

Qube Research & Technologies (QRT) first reported a position in TELA in Q4 2019 and held it in 5 quarters. The position peaked at $210K in Q1 2023. 47 funds tracked by Wall St. Rank hold TELA as of Q4 2024.

  • Qube Research & Technologies (QRT) reported no remaining TELA Bio position as of Q4 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 10,113 TELA Bio shares in Q4 2024, an estimated $25.6K.
  • Qube Research & Technologies (QRT) first reported a position in TELA Bio in Q4 2019 and held it in 5 quarters.
  • Qube Research & Technologies (QRT)'s TELA Bio position peaked at $210K in Q1 2023.
  • 47 funds tracked by Wall St. Rank held TELA Bio as of Q4 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2024, filed 14 Feb 2025.